Dalbavancin
- Strength
- 500 mg/25mL
- Form
- Injection, Powder, Lyophilized, For Solution
- Class
- Lipoglycopeptide Antibacterial
Somerset Therapeutics, LLC
Not stocked by us — reference only
dalbavancin hydrochloride
Listed by Long Grove Pharmaceuticals, LLC
| Dosage form | Injection, Powder, For Solution |
|---|---|
| Route | Intravenous |
| Drug class | Lipoglycopeptide Antibacterial |
| Approval route | ANDA — approved generic |
| NDC code | 81298-2390 |
| FDA application | ANDA218602 |
| RxNorm concept | 1539243 |
| Package sizes listed | 1 |
| Marketed since | March 2026 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Somerset Therapeutics, LLC
Not stocked by us — reference only
Teva Pharmaceuticals, Inc.
Not stocked by us — reference only
Meitheal Pharmaceuticals Inc
Not stocked by us — reference only
BE Pharmaceuticals Inc.
Not stocked by us — reference only
Fresenius Kabi USA, LLC
Not stocked by us — reference only
Dalbavancin
Allergan, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.